Insider Transactions in Q1 2025 at Inovio Pharmaceuticals, Inc. (INO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2025
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,944
+1.14%
|
-
|
|
Feb 26
2025
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,322
-8.94%
|
$5,322
$1.98 P/Share
|
|
Feb 26
2025
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,007
+13.13%
|
-
|
|
Feb 26
2025
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,581
-11.32%
|
$11,581
$1.98 P/Share
|
|
Feb 26
2025
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,484
+19.0%
|
-
|
|
Feb 26
2025
|
Michael John Sumner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,010
+27.47%
|
-
|
|
Feb 26
2025
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,643
-6.07%
|
$3,643
$1.98 P/Share
|
|
Feb 26
2025
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,865
+12.85%
|
-
|